Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Reframing small cell lung cancer: therapeutic lessons from hematologic malignancies.

Frontiers in oncology·2026
Same author

HDAC inhibition unlocks tumor plasticity and enhances immunotherapy response in Myc-driven small cell lung cancer.

Molecular cancer therapeutics·2026
Same author

Integrative molecular analyses of lineage identity and morphology in aggressive variant prostate cancer.

NPJ precision oncology·2026
Same author

Long-Term Outcomes of Surgery for Thymic Epithelial Tumors With Pleural Metastases.

JTO clinical and research reports·2026
Same author

Cancer Prevention Clinical Trials: Advances and Challenges.

Cancers·2026
Same author

Corrigendum to 'Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact' [Journal of Thoracic Oncology Volume 21 Issue 1 (2026) 41-76].

Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer·2026

Related Experiment Video

Updated: May 11, 2026

Examination of Thymic Positive and Negative Selection by Flow Cytometry
14:29

Examination of Thymic Positive and Negative Selection by Flow Cytometry

Published on: October 8, 2012

22.5K

Immune aberrations in thymic epithelial tumors.

Kanak Parmar1, Arun Rajan2

  • 1National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD, USA.

Mediastinum (Hong Kong, China)
|January 8, 2026
PubMed
Summary
This summary is machine-generated.

Thymic epithelial tumors (TETs) show distinct immune cell profiles and microenvironments. Understanding these differences is crucial for predicting autoimmunity risk and immunotherapy toxicity.

Keywords:
T cell developmentThymomaimmune profiletumor microenvironment (TME)

More Related Videos

Isolation, Identification, and Purification of Murine Thymic Epithelial Cells
07:20

Isolation, Identification, and Purification of Murine Thymic Epithelial Cells

Published on: August 8, 2014

33.2K
Preparation of Single-Cell Suspension of Mouse Thymic Epithelial Cells and Staining of Intracellular Molecules for Flow Cytometric AnalysisMechanisms
09:41

Preparation of Single-Cell Suspension of Mouse Thymic Epithelial Cells and Staining of Intracellular Molecules for Flow Cytometric AnalysisMechanisms

Published on: July 26, 2024

1.5K

Related Experiment Videos

Last Updated: May 11, 2026

Examination of Thymic Positive and Negative Selection by Flow Cytometry
14:29

Examination of Thymic Positive and Negative Selection by Flow Cytometry

Published on: October 8, 2012

22.5K
Isolation, Identification, and Purification of Murine Thymic Epithelial Cells
07:20

Isolation, Identification, and Purification of Murine Thymic Epithelial Cells

Published on: August 8, 2014

33.2K
Preparation of Single-Cell Suspension of Mouse Thymic Epithelial Cells and Staining of Intracellular Molecules for Flow Cytometric AnalysisMechanisms
09:41

Preparation of Single-Cell Suspension of Mouse Thymic Epithelial Cells and Staining of Intracellular Molecules for Flow Cytometric AnalysisMechanisms

Published on: July 26, 2024

1.5K

Area of Science:

  • Oncology
  • Immunology
  • Cell Biology

Background:

  • Thymic epithelial tumors (TETs) are rare cancers linked to autoimmunity.
  • The thymus is vital for T cell development, influencing autoimmune disease risk.
  • TETs exhibit unique clinical, genomic, and immunological characteristics.

Purpose of the Study:

  • To review recent advances in thymic biology and tumor immunology.
  • To frame the immune landscape of TETs based on histology.
  • To understand TETs' predisposition to autoimmunity and immunotherapy toxicity.

Main Methods:

  • Review of recent studies on TET immune cell composition.
  • Analysis of tumor immune microenvironment differences between thymomas and thymic carcinomas (TCs).
  • Examination of histology-based variations in T cell receptor diversity and cytokine profiles.

Main Results:

  • Thymomas have more immature T cells; TCs have more differentiated T cells.
  • Immune cell infiltration is higher in thymomas, while TCs show a prominent stromal signature.
  • Differences in B cells, dendritic cells, macrophages, and regulatory T cells exist based on TET histology.

Conclusions:

  • Immune cell composition and microenvironment vary significantly with TET histology.
  • Understanding TET immune landscapes is key for managing autoimmunity and immunotherapy side effects.
  • Further research is needed to fully elucidate the immune basis of TETs and associated conditions.